IRCT20150630022991N14 IRCT 2018-11-22 Babol University of Medical Sciences Escitalopram in breast cancer patients Effect of escitalopram on pain, anxiety and depression in patients with breast cancer 2018-11-06 anticipated 40 Complete https://irct.ir/trial/34451 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The distribution of patients in the two treatment groups is conducted by block random allocation method. The free website of www.randomization.com is used to generate the allocation sequence. The resulting sequence is written in separate sheets and placed in sealed envelopes and is provided to the main investigator for the study, Blinding description: The patients do not know about the type of drug or placebo which they receive. 2 Malignant neoplasm of breast. Intervention 1: Intervention group: 10 milligram per day escitalopram capsule manufactured in Abidi Pharmaceutical Company for four weeks. Intervention 2: Control group: One placebo capsule containing starch for four weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.